Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 2:28 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 138 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Fat Digestion Clear all

Conditions: Total Parenteral Nutrition-induced Cholestasis
Interventions: Omegaven, Omegaven; Dietary Supplement · Drug
Lead sponsor: Pediatrix; Other
Eligibility: 14 Days to 2 Years
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Systemic Lupus Erythematosus, Arthritic Psoriasis, Psoriasis, Inflammatory Bowel Diseases
Interventions: BMS-986165 Capsule, BMS-986165 Tablet; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Lenexa, Kansas

Conditions: MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis), Fatty Liver Disease, Nonalcoholic
Interventions: Thermoacoustic Enhanced Ultrasound; Device
Lead sponsor: Endra Lifesciences; Industry
Eligibility: 18 Years and older
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Impaired Fasting Glucose, Pre Diabetes, Liver Fat
Interventions: Dietary intervention; Dietary Supplement
Lead sponsor: Mayo Clinic; Other
Eligibility: 30 Years to 80 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Metabolic Associated Fatty Liver Disease, Metabolic Associated Steatotic Liver Disease, Cirrhosis, Liver, NASH, Liver Fibrosis, Liver Fat, Liver Steatoses, Liver Inflammation
Interventions: Not listed
Lead sponsor: Foundation for the National Institutes of Health; Other
Eligibility: 18 Years to 75 Years
Enrollment: 400 participants
Timeline: 2025 – 2027
U.S. locations: 4
States / cities: Miami, Florida • Columbus, Ohio • Bellaire, Texas + 1 more

Conditions: Cholestasis, Cholestasis of Parenteral Nutrition
Interventions: Omegaven; Drug
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 14 Days to 5 Years
Enrollment: 293 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2020
U.S. locations: 2
States / cities: Houston, Texas

Conditions: Vitamin D Deficiency, Gastrointestinal Diseases
Interventions: Sperti Lamp; Device
Lead sponsor: Boston University; Other
Eligibility: 18 Years to 64 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Pancreatitis
Interventions: Creon36™; Drug
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 30 Years to 70 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Non-alcoholic Fatty Liver, Metabolic Syndrome
Interventions: Fat-Free Milk, Low-Fat Milk, Full-Fat Milk, Soy Milk; Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Cancer Patients Receiving Chemotherapy or Chemoradiotherapy
Interventions: Daily intake for 10 weeks (+/- 2 weeks); Dietary Supplement
Lead sponsor: Texas A&M University; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: College Station, Texas

Conditions: Nonalcoholic Fatty Liver
Interventions: Soybean Oil Foods, Palm Oil Foods; Other
Lead sponsor: Ohio State University; Other
Eligibility: 22 Years to 80 Years
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Gastroesophageal Reflux Disease, Overweight, Acid Reflux Disease
Interventions: Diet - very low carb or low fat; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 70 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Cholestasis, Total Parenteral Nutrition-induced Cholestasis
Interventions: Omegaven; Drug
Lead sponsor: Cindy Haller; Other
Eligibility: 2 Weeks to 5 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 2
States / cities: Manhasset, New York • New Hyde Park, New York

Conditions: Tumor Hyperinsulinism (Tumor HI)
Interventions: Ersodetug; Drug
Lead sponsor: Rezolute; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 8
States / cities: Chicago, Illinois • Bethesda, Maryland • Boston, Massachusetts + 5 more

Conditions: Diabetes Mellitus, Type 2
Interventions: High-Fruit Diet; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 20 Years to 70 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Obesity, Fatty Liver, Nonalcoholic
Interventions: pitavastatin, PLACEBO; Drug · Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 40 Years to 65 Years · Male only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Polycystic Ovary Syndrome, Non-Alcoholic Fatty Liver Disease, Metabolic Syndrome
Interventions: Not listed
Lead sponsor: Columbia University; Other
Eligibility: 14 Years to 25 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer, Appendix Cancer, Brain Tumor, Glioblastoma, Astrocytoma, Bile Duct Cancer, Cholangiocarcinoma, Bladder Cancer, Bone Cancer, Synovial Sarcoma, Chondrosarcoma, Liposarcoma, Sarcoma, Kaposi, Sarcoma,Soft Tissue, Sarcoma, Osteosarcoma, CNS Cancer, Brain Stem Neoplasms, Breast Cancer, Cervical Cancer, Colorectal Cancer, Rectal Cancer, Colon Cancer, Esophageal Cancer, Esophagus Cancer, Cancer of Colon, Pancreatic Cancer, Cancer of Pancreas, Testis Cancer, Testicular Cancer, Ureter Cancer, Renal Cell Carcinoma, Kidney Cancer, Gestational Trophoblastic Tumor, Head and Neck Neoplasms, Parotid Tumor, Larynx Cancer, Tongue Cancer, Pharynx Cancer, Salivary Gland Cancer, Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Multiple Myeloma, Non Hodgkin Lymphoma, Carcinoid Tumor, Lung Cancer, Neuroendocrine Tumors, Mesothelioma, Thyroid Cancer, Parathyroid Neoplasms, Adrenal Cancer, Small Bowel Cancer, Stomach Cancer, Liver Cancer, Hepatic Cancer, Melanoma, Skin Cancer, Unknown Primary Tumors, Uterine Cancer, Fallopian Tube Cancer, Ovarian Cancer, Prostate Cancer, Vaginal Cancer, Penile Cancer, Vulvar Cancer, Waldenstrom Macroglobulinemia, Cancer, Advanced, Thymus Cancer, Nasopharyngeal Carcinoma, Multiple Endocrine Neoplasia, Pheochromocytoma, Small Cell Carcinoma, Pulmonary Carcinoma
Interventions: Biomarker Testing (L), Systemic Treatment (T), Patient Reported Outcomes (P); Diagnostic Test · Drug · Other
Lead sponsor: Taproot Health; Industry
Eligibility: 18 Years and older
Enrollment: 167 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 2
States / cities: Idaho Falls, Idaho • Laredo, Texas

Conditions: Liver Cancer, Rhabdomyosarcoma, Malignant Rhabdoid Tumor, Liposarcoma, Wilms Tumor, Yolk Sac Tumor
Interventions: AGAR T cells; Genetic
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 1 Year to 21 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2040
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Non-Alcoholic Fatty Liver Disease
Interventions: Magnetic Resonance Imaging (MRI), Ultrasound Imaging; Device
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 16 Years and older
Enrollment: 192 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Fatty Liver
Interventions: Group 1 NRPT, Group 2 NRPT, Group 3 Placebo; Dietary Supplement · Other
Lead sponsor: Elysium Health; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 111 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 9
States / cities: Hialeah, Florida • Lake Worth, Florida • Miami, Florida + 5 more

Conditions: Breast Cancer
Interventions: Not listed
Lead sponsor: Texas A&M University; Other
Eligibility: 30 Years and older
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: College Station, Texas

Conditions: Hepatic Steatosis, Polycystic Ovarian Syndrome, Obesity
Interventions: Byetta 5Mcg Pen Injection; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 12 Years to 21 Years · Female only
Enrollment: 92 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2022
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Cholestasis, Cholestasis of Parenteral Nutrition
Interventions: Omegaven; Drug
Lead sponsor: University of South Florida; Other
Eligibility: 14 Days and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Tampa, Florida

Search by objective public record fields.

Intravenous Fat Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury in Infants

A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation

Thermoacoustic Method for Estimating Liver Fat Fraction

Dietary Interventions in Prediabetes

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

Compassionate Use of an Intravenous Fish Oil Emulsion in the Treatment of Liver Injury in Infants

Ultraviolet Light And Vitamin D In Subjects With Fat Malabsorption Or After Gastric Bypass Surgery

Fat Malabsorption in Chronic Pancreatitis

Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome

Nutrition Intervention During Chemotherapy

Weight, Energy, Lipids, and the Liver (WELL) Study

Study to Evaluate the Effect of a Very Low Carbohydrate Diet on Gastroesophageal Reflux Disease

Compassionate Use of Omegaven IV Fat Emulsion

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

Effect of Whole Fruit on Glycemic Control in Adults With Type 2 Diabetes

Effects of Pitavastatin on Insulin Sensitivity and Liver Fat

NAFLD in Adolescents and Young Adults With PCOS

The Registry of Oncology Outcomes Associated With Testing and Treatment

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

Ultrasound Quantification of Liver Fat

Study to Assess the Relationship Between Daily Dosing of NRPT and Changes in Liver Fat in Healthy Volunteers

Fat Metabolism Following Chemotherapy in Breast Cancer

Liver and Fat Regulation in Overweight Adolescent Girls

Omegaven as Alternative Parenteral Fat Nutrition